These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23982716)

  • 41. Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III.
    Simpson KN; Simpson AN; Mauldin PD; Palesch YY; Yeatts SD; Kleindorfer D; Tomsick TA; Foster LD; Demchuk AM; Khatri P; Hill MD; Jauch EC; Jovin TG; Yan B; von Kummer R; Molina CA; Goyal M; Schonewille WJ; Mazighi M; Engelter ST; Anderson C; Spilker J; Carrozzella J; Ryckborst KJ; Janis LS; Broderick JP;
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28483774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis of thrombolytic treatment for stroke.
    Mar J; Begiristain JM; Arrazola A
    Cerebrovasc Dis; 2005; 20(3):193-200. PubMed ID: 16088115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A model of cost-effectiveness of tissue plasminogen activator in patient subgroups 3 to 4.5 hours after onset of acute ischemic stroke.
    Boudreau DM; Guzauskas G; Villa KF; Fagan SC; Veenstra DL
    Ann Emerg Med; 2013 Jan; 61(1):46-55. PubMed ID: 22633340
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Status of prehospital delay and intravenous thrombolysis in the management of acute ischemic stroke in Nepal.
    Nepal G; Yadav JK; Basnet B; Shrestha TM; Kharel G; Ojha R
    BMC Neurol; 2019 Jul; 19(1):155. PubMed ID: 31288770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria.
    Murray NM; Ke M; Yee A; Chen C; Wong C; Bedenk A; Fernandes J; Barazangi N; Tong D
    J Stroke Cerebrovasc Dis; 2019 Sep; 28(9):2488-2495. PubMed ID: 31277995
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.
    Katzan IL; Hammer MD; Hixson ED; Furlan AJ; Abou-Chebl A; Nadzam DM;
    Arch Neurol; 2004 Mar; 61(3):346-50. PubMed ID: 15023810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing delay to stroke thrombolysis--lessons learnt from the Stroke 90 Project.
    Kendall J; Dutta D; Brown E
    Emerg Med J; 2015 Feb; 32(2):100-4. PubMed ID: 24064044
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The economics of treating stroke as an acute brain attack.
    Bogousslavsky J; Paciaroni M
    BMC Med; 2009 Sep; 7():51. PubMed ID: 19775424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantifying the Benefit of Prehospital Rapid Treatment in Acute Stroke: Benchmark for Future Innovative Clinical Trials.
    Lorenz MW; Lauer A; Foerch C
    Stroke; 2015 Nov; 46(11):3168-76. PubMed ID: 26443833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X; Hu HT; Liu S; Sun YH; Gao X
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single-center, 2-year experience.
    Koennecke HC; Nohr R; Leistner S; Marx P
    Stroke; 2001 May; 32(5):1074-8. PubMed ID: 11340212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic thrombolytic therapy in acute ischemic stroke--new experiences in spreading network of stroke units in Croatia.
    Matijević V; Poljaković Z; Malojčić B; Mišmaš A; Bazina A; Boban M; Bilić I; Radanović B; Glavor KD; Kiđemet-Piskač S; Habek M
    J Neurol Sci; 2012 Mar; 314(1-2):126-9. PubMed ID: 22063080
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Target: Stroke Was Associated With Faster Intravenous Thrombolysis and Improved One-Year Outcomes for Acute Ischemic Stroke in Medicare Beneficiaries.
    Man S; Xian Y; Holmes DN; Matsouaka RA; Saver JL; Smith EE; Bhatt DL; Schwamm LH; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2020 Dec; 13(12):e007150. PubMed ID: 33302714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Time cost of a nonclosing intravenous thrombolysis service for acute ischemic stroke.
    Sun MC; Hsiao PJ
    J Formos Med Assoc; 2015 Oct; 114(10):910-5. PubMed ID: 26239194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of golden hour thrombolysis: a Prehospital Acute Neurological Treatment and Optimization of Medical Care in Stroke (PHANTOM-S) substudy.
    Ebinger M; Kunz A; Wendt M; Rozanski M; Winter B; Waldschmidt C; Weber J; Villringer K; Fiebach JB; Audebert HJ
    JAMA Neurol; 2015 Jan; 72(1):25-30. PubMed ID: 25402214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictive value of the Cincinnati Prehospital Stroke Scale for identifying thrombolytic candidates in acute ischemic stroke.
    You JS; Chung SP; Chung HS; Lee HS; Park JW; Kim HJ; Lee SH; Park I; Lee HS
    Am J Emerg Med; 2013 Dec; 31(12):1699-702. PubMed ID: 24055479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes.
    Sheth KN; Smith EE; Grau-Sepulveda MV; Kleindorfer D; Fonarow GC; Schwamm LH
    Stroke; 2015 Mar; 46(3):732-9. PubMed ID: 25672784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry.
    Tsivgoulis G; Katsanos AH; Kadlecová P; Czlonkowska A; Kobayashi A; Brozman M; Švigelj V; Csiba L; Fekete K; Kõrv J; Demarin V; Vilionskis A; Jatuzis D; Krespi Y; Karapanayiotides T; Giannopoulos S; Mikulik R
    Eur J Neurol; 2017 Dec; 24(12):1493-1498. PubMed ID: 28888075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.